Nearly two-thirds of Americans don't have sufficient vitamin D. GrassrootsHealth's population data puts it plainly: only 34.5% of people tested land in the "sufficient" range, while 2.6% are severely deficient and another 40.9% sit in insufficient territory[1]. It's worse in winter, worse for people who stay indoors, and worse for anyone who has spent the last few years treating a multivitamin bottle as optional.
What's changed less than the headlines suggest: NHANES survey data tracked from 2001 through 2018 shows overall U.S. deficiency rates have stayed roughly flat for two decades, even as average serum levels crept up slightly. The one group moving in the wrong direction is adults aged 20-39 — their vitamin D levels actually declined over that period, and deficiency rose fastest among lower-income adults in that bracket[2]. If you're in your 20s or 30s and you've never had your level checked, the data says you're not the exception.
Why D3 alone isn't the whole answer
Taking vitamin D3 by itself solves one problem and quietly creates pressure on another. D3's main job is pulling more calcium out of your gut and into your bloodstream. But calcium in the blood has to go somewhere, and vitamin D3 doesn't control where that is — vitamin K2 does.
The mechanism is specific: vitamin D3 stimulates production of two proteins, osteocalcin and matrix Gla protein (MGP), that are responsible for directing calcium into bone and keeping it out of soft tissue and artery walls. But those proteins are made in an inactive form. They need vitamin K2 to "activate" them — a carboxylation step K2 performs and D3 cannot[3]. Without enough K2 on hand, D3 supplementation raises the amount of calcium available for the body to use, without necessarily improving where it ends up.
This is why the two nutrients are studied together rather than separately. Vitamin K research summarized by the National Institutes of Health's PMC archive describes vitamin D and vitamin K as functioning through a genuinely synergistic pathway for bone mineralization — not two supplements that happen to be sold in the same bottle, but two steps of one process[3]. A case report circulated in Bio Absorb's clinical review makes the stakes concrete: a 72-year-old osteoporosis patient scheduled for spinal fusion surgery had K2 added to her existing D3-and-calcium regimen, and six months later imaging showed complete vertebral fusion with measurably improved bone density markers[4].
What "K2" actually means on a label
Not all K2 is identical. The form that shows up in most synergy research and most quality supplements is MK-7 (menaquinone-7), valued because it stays active in the bloodstream far longer than the shorter-chain MK-4 form or plain K1 — giving it more time to do the carboxylation work D3 depends on[3][5]. When you're comparing a D3+K2 product, the K2 source and form matter as much as the D3 dose.
Where format comes in
D3 and K2 are both fat-soluble, which is exactly why capsules and softgels have been the default delivery format — the vitamins need to travel with some fat to absorb well through the gut wall. That's not wrong, but it does mean the whole dose is riding on digestion working normally, on the same schedule every day, with food.
A fast-dissolving oral strip changes where absorption starts. Formats built for the mouth's mucosal tissue — rather than requiring a swallow-and-digest cycle — are being explored specifically for fat-soluble vitamins like D3 and K2 because the strip begins dissolving on contact with saliva, without needing a full meal alongside it to get moving[6]. For a nutrient pairing where consistency is the entire point — you don't get osteocalcin activation from a dose you skipped — removing the "did I take this with food" variable is a real, practical difference, not a marketing footnote.
Where CORE fits
The CORE strip pairs vitamin D3 with K2 in a single fast-dissolving format — no softgel, no water, no need to time it around a meal. If you're one of the roughly two-thirds of adults GrassrootsHealth's data says aren't at a sufficient level, or you fall into the 20-39 bracket where NHANES shows the trend actually worsening, that's the gap CORE is built to close — the whole synergistic pathway, not just half of it.